GynecologyGynecology2079-56962079-5831Consilium Medicum7601510.26442/20795696.2021.6.201173Research ArticleEndometriomas: the effectiveness of combination treatmentArtymukNatalia V.<p>D. Sci. (Med.), Prof.</p>artymuk@gmail.comhttps://orcid.org/0000-0001-7014-6492ZotovaOlga A.<p>Cand. Sci. (Med.)</p>olga-tulpan@rambler.ruhttps://orcid.org/0000-0002-4991-5354VaulinaEkaterina N.<p>obstetrician-gynecologist</p>vaulina.en@mail.ruhttps://orcid.org/0000-0001-7816-9197Kemerovo State Medical UniversityBelyaev Kuzbass Regional Clinical Hospital151220212365365411307202108122021Copyright © 2021, Consilium Medicum2021<p><strong>Aim. </strong>Evaluate the effectiveness of combined treatment and establish the frequency of recurrence of the ovarian endometrioma.</p>
<p><strong>Materials and methods. </strong>The prospective observational study evaluating the effectiveness of combined treatment of endometriomas, established the frequency of relapse after treatment. 186 patients with an established diagnosis of endometriosis of the ovaries were monitored, who underwent operative treatment in the volume of laparoscopic cystectomy. 95.0% of patients received anti-relapse hormonal treatment.</p>
<p><strong>Results. </strong>Against the background of treatment, positive dynamics were noted: dyspareunia, hyperspolymenorrhea and pre- and postmenstrual bloody discharge were stopped in 98.7% of cases, dysmenorrhea in 97.4% of cases, chronic pelvic pain in 94.8% cases. Pregnancy occurred in 11.7% of cases (1.3% of which when using assisted reproduction). The recurrence rate of endometriomas after 2 years was 1.4%, after 3 years 3.7%.</p>
<p><strong>Conclusion. </strong>Combination treatment was effective in reducing the severity or completely cured the symptoms of endometrioid ovarian cysts in 95% of women. The recurrence rate of endometriomas after 2 years was 1.4%, after 3 years 3.7%.</p>ovarian endometriosishormonal therapytreatment effectivenessэндометриома яичникагормональная терапиярецидивэффективность лечения[Шалина М.А., Ярмолинская М.И., Абашова Е.И. Влияние гормональной терапии на костную ткань: мифы и реальность. Журнал акушерства и женских болезней. 2018;67(3):83-94 [Shalina MA, Yarmolinskaya MI, Abashova EI. The effect of hormone therapy on bone tissue: myths and reality. Journal of Obstetrics and Women's Diseases. 2018;67(3):83-94 (in Russian)]. DOI:10.17816/JOWD67383-94][Muzii L, Tucci CD, Feliciantonio MD, et al. Management of endometriomas. Semin Reprod Med. 2017;35:25-30. DOI:10.1055/s-0036-1597126][Filip L, Duică F, Prădatu A, et al. Endometriosis Associated Infertility: A Critical Review and Analysis on Etiopathogenesis and Therapeutic Approaches. Medicina (Kaunas). 2020;56(9):460. DOI:10.3390/medicina56090460][Качалина Т.С., Зиновьев А.Н., Богатова М.Е. Комплексная оценка факторов риска развития рецидива эндометриоидных кист яичников. Медицинский альманах. 2017;1(46):107-10 [Kachalina TS, Zinoviev AN, Bogatova ME. Comprehensive assessment of risk factors for the development of recurrence of endometrioid ovarian cysts. Medical Almanac. 2017;1(46):107-10 (in Russian)].][Радзинский В.Е., Оразов М.Р., Локшин В.Н., и др. Бесплодный брак. Версии и контраверсии. М.: ГЭОТАР-Медиа, 2018 [Radzinskii VE, Orazov MR, Lokshin VN, et al. Besplodnyi brak. Versii i kontraversii. Moscow: GEOTAR-Media, 2018 (in Russian)].][Михалева Л.М., Соломатина А.А., Хованская Т.Н., и др. Морфофункциональное состояние и рецептивность эндометрия у пациенток с эндометриозом яичников. Проблемы репродукции. 2020;26(3):68-75 [Mikhaleva LM, Solomatina AA, Khovanskaya TN, et al. Morphofunctional state and receptivity of the endometrium in patients with ovarian endometriosis. Reproduction Problems. 2020;26(3):68-75 (in Russian)]. DOI:10.17116/repro20202603168][Rubod C, Gean Dit Gautier E, Yazbeck C. Traitement chirurgical des endométriomes. Modalités et résultats en termes de douleur, fertilité et récidive des techniques chirurgicales et de ses alternatives. RPC Endométriose CNGOF-HAS. Gynécologie Obs Fertil Sénologie. 2018;46(3):278-29. DOI:10.1016/j.gofs.2018.02.013][Габидуллина Р.И., Кошельникова Е.А., Шигабутдинова Т.Н., и др. Эндометриоз: влияние на фертильность и исходы беременности (обзор литературы). Гинекология. 2020;22(6):12-7 [Gabidullina RI, Koshelnikova EA, Shigabutdinova TN, et al. Endometriosis: impact on fertility and pregnancy outcomes (literature review). Gynecology. 2020;22(6):12-7 (in Russian)]. DOI:10.26442/20795696.2020.6.200477][Эндометриоз. Клинические рекомендации Минздрава России. 2020 [Endometrioz. Klinicheskie rekomendatsii Minzdrava Rossii. 2020 (in Russian)].][Артымук Н.В., Данилова Л.Н., Червов В.О., и др. Сравнительная оценка комбинированного лечения пациенток, страдающих эндометриозом и бесплодием, с применением агонистов гонадотропин-рилизинг-гормона и диеногеста. Проблемы репродукции. 2017;23(2):61-5 [Artymuk NV, Danilova LN, Chervov VO, еt al. Comparative evaluation of combined treatment of patients suffering from endometriosis and infertility with the use of gonadotropin-releasing hormone agonists and dienogest. Reproduction Problems. 2017;23(2):61-5 (in Russian)]. DOI:10.17116/repro201723261-65][Nickkho-Amiry M, Savant R, Majumder K, et al. The effect of surgical management of endometrioma on the IVF/ICSI outcomes when compared with no treatment. A systematic review and meta-analysis. Neuro Endocrinol Lett. 2016;37(4):295-300. DOI:10.1007/s00404-017-4640-1][Yong P, Alsowayan N, Noga H, et al. CHC for pelvic pain in women with endometriosis: ineffectiveness or discontinuation due to side-effects. Hum Reprod Open. 2020;2020(2):hoz040. DOI:10.1093/hropen/hoz040][Agarwal S, Antunez-Flores O, Foster W, et al. Real-world characteristics of women with endometriosis-related pain entering a multidisciplinary endometriosis program. BMC Women’s Health. 2021;21:19. DOI:10.1186/s12905-020-01139-7][Артымук Н.В., Зотова О.А., Шакирова Е.А., и др. Эффективность комбинированного лечения эндометриом яичников. Эндоскопическая хирургия. 2019;25(2):35-9 [Artymuk NV, Zotova OA, Shakirova EA, et al. The effectiveness so combined treatment of ovarian endometriomas. Endoscopic Surgery. 2019;25(2):35-9 (in Russian)]. DOI:10.17116/endoskop20192502135][Li X-Y, Chao X-P, Leng J-H, et al. Risk factors for postoperative recurrence of ovarian endometriosis: long-term follow-up of 358 women. J Ovarian Res. 2019;12(1):79. DOI:10.1186/s13048-019-0552-y][Deckers P, Ribeiro SC, Simoes RDS, et al. Systematic review and meta-analysis of the effect of bipolar electrocoagulation during laparoscopic ovarian endometrioma stripping on ovarian reserve. Int J Gynaecol Obstet. 2018;140(1):11-7. DOI:10.1002/ijgo.12338][Адамян Л.В., Артымук Н.В., Ермакова О.А. Формуляр лекарственных средств в акушерстве и гинекологии. М.: ГЭОТАР-Медиа, 2011 [Adamian LV, Artymuk NV, Ermakova OA. Formuliar lekarstvennykh sredstv v akusherstve i ginekologii. Moscow: GEOTAR-Media, 2011 (in Russian)].][Kitajima M, Matsumoto K, Murakami N, et al. Ovarian reserve after three-step laparoscopic surgery for endometriomas utilizing dienogest: A pilot study. Reprod Med Biol. 2020;19(4):425-31. DOI:10.1002/rmb2.12349][Cesana MC, Ferrari L, Passoni P, et al. Reproductive prognosis in women with endometriosis after conservative surgery: a single-center experience. Minerva Ginecol. 2017;69(4):322-27. DOI:10.23736/S0026-4784.16.03988-5][Zhu S, Zhu Y, Liu Y, Zhang H. Comparison of outcomes of different postoperative hormone therapy in the treatment of ovarian endometriosis: a brief report. Adv Ther. 2018;35(6):857-63. DOI:10.1007/s12325-018-0715-z]